Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Neurological disorders

    - PMLiVE

    WHO urges US to ‘reconsider’ withdrawal from global health organisation

    President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

    - PMLiVE

    WHO launches $1.5bn emergency appeal to tackle ongoing health crises

    The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people

    - PMLiVE

    WHO announces priority endemic pathogens for urgent vaccine development

    The study identifies the 17 pathogens that regularly cause diseases in communities

    - PMLiVE

    WHO announces new mRNA vaccine development initiative against human avian influenza

    H5N1 was responsible for 889 cases and 463 deaths across 23 countries from 2003 to 2024

    - PMLiVE

    WHO and CEPI call for broader research strategy to prepare for future pandemics

    They have highlighted the importance of expanding research to entire families of pathogens

    - PMLiVE

    WHO calls for better medicines access to close neurological disorders treatment gap

    In 2021, neurological conditions affected more than three billion people worldwide

    - PMLiVE

    WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer

    In more than nine out of ten cases, the HPV virus leads to cervical cancer, the fourth most common cancer in women globally

    - PMLiVE

    WHO publishes new toolkit to improve services for neurological disorders

    Neurological conditions such as dementia and stroke were responsible for more than three billion cases globally in 2021

    - PMLiVE

    Takeda shares long-term results for HyQvia in rare neurological disorder CIDP

    The therapy is the first and only facilitated subcutaneous immunoglobulin treatment for CIDP

    - PMLiVE

    WHO publishes latest report on development of antibacterial agents worldwide

    AMR is designated as one of the top ten global public health threats facing humanity

    - PMLiVE

    WHO updates drug-resistant bacteria list to develop new treatments for AMR

    The 2024 BPPL list includes 15 families of antibiotic-resistant bacteria

    - PMLiVE

    Governments continue proposed pandemic agreement progress ahead of World Health Assembly

    The meeting focusing on ‘All for Health, Health for All’ takes place on 27 May to 7 June 2024

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links